Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lipid-lowering drugs.

K Pahan1

  • 1Section of Neuroscience, Department of Oral Biology, University of Nebraska Medical Center, 40th and Holdrege, Lincoln, Nebraska 68583, USA. kpahan@unmc.edu

Cellular and Molecular Life Sciences : CMLS
|March 29, 2006
PubMed
Summary

Lipid-lowering drugs like statins and fibrates not only manage hyperlipidemia but also show promise for treating cancer, autoimmunity, and neurodegenerative diseases due to their anti-inflammatory and immune-modulating effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Attenuation of microglial RANTES by NEMO-binding domain peptide inhibits the infiltration of CD8(+) T cells in the nigra of hemiparkinsonian monkey.

Neuroscience·2015
Same author

Heat sensitivity of mercuric ion and organomercurial degrading enzymes of aquatic, mercury-resistant bacteria.

World journal of microbiology & biotechnology·2014
Same author

Studies on the mercury volatilizing enzymes in nitrogen-fixing Beijerinckia mobilis.

World journal of microbiology & biotechnology·2014
Same author

Role of cytokine p40 family in multiple sclerosis.

Minerva medica·2008
Same author

HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis.

Cell death and differentiation·2005
Same author

Regulation of TNF-alpha-induced IL-6 production in MG-63 human osteoblast-like cells.

Journal of dental research·2002

Area of Science:

  • Pharmacology and Therapeutics
  • Cardiovascular Medicine
  • Oncology

Background:

  • Hyperlipidemia management traditionally relies on lifestyle changes and lipid-lowering medications.
  • Statins primarily reduce cholesterol, while fibrates target fatty acids and triglycerides.
  • Other agents like ezetimibe and niacin are also used for hyperlipidemia treatment.

Purpose of the Study:

  • To explore the emerging therapeutic applications of lipid-lowering drugs beyond their primary function.
  • To discuss the novel mechanisms of action of statins and fibrates in various disease contexts.
  • To highlight the potential of these drugs in treating cancer, autoimmune disorders, inflammation, and neurodegeneration.

Main Methods:

  • Review of recent scientific literature on the pleiotropic effects of lipid-lowering drugs.
  • Analysis of studies investigating the impact of statins and fibrates on intracellular signaling, inflammation, and immune responses.
  • Synthesis of evidence linking these mechanisms to potential therapeutic benefits in non-cardiovascular diseases.

Main Results:

  • Statins and fibrates possess functions beyond lipid reduction, including modulating intracellular pathways.
  • These drugs exhibit anti-inflammatory properties and can suppress reactive oxygen species production.
  • Evidence suggests modulation of T cell activity, indicating potential roles in immune-related disorders.

Conclusions:

  • Lipid-lowering drugs, particularly statins and fibrates, demonstrate pleiotropic effects with therapeutic potential.
  • Their ability to modulate inflammation and immune responses opens avenues for treating conditions like cancer and neurodegeneration.
  • Further research into these novel mechanisms could lead to expanded clinical applications for existing medications.

Related Experiment Videos